Literature DB >> 11728796

I get tired for no reason: a single item screening for cancer-related fatigue.

K L Kirsh1, S Passik, E Holtsclaw, K Donaghy, D Theobald.   

Abstract

This study examined the criterion validity and sensitivity and specificity of a single item to rapidly screen patients in ambulatory oncology clinics for cancer-related fatigue. In an effort to expand the utility of the Zung Self-Rating Depression Scale (ZSDS) as a screen for other symptoms, the utility of the single fatigue item was examined. The fatigue item reads "I get tired for no reason" and is rated on a four-point scale ranging from "none or a little of the time" to "most or all of the time." Fifty-two subjects were administered the Zung, the Functional Assessment of Cancer Therapy-Anemia (FACT-An) scale, and the Fatigue Symptom Inventory (FSI). The Zung item was highly correlated with the ZSDS (r= 0.63, p < 0.0001) and the FACT-An (r = -0.70, p < 0.0001), as well as to the individual items of the FSI, ranging from 0.41 (p < 0.003) to 0.71 (p < 0.0001). All 10 subjects considered to be depressed based on the ZSDS were also considered to fatigued on the FACT-An. Setting the ZSDS item cutoff point at level 3--"A good part of the time"--yielded a sensitivity of 78.95% and a specificity of 87.88%. It is concluded that a single item can be a fast and accurate way of screening cancer patients for fatigue to trigger additional follow-up, thus expanding the utility of a depression screening tool for problems other than the purely psychiatric.

Entities:  

Mesh:

Year:  2001        PMID: 11728796     DOI: 10.1016/s0885-3924(01)00350-5

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  16 in total

1.  A flexible item to screen for depression in inner-city minorities during palliative care symptom assessment.

Authors:  Richard Benoit Francoeur
Journal:  Am J Geriatr Psychiatry       Date:  2006-03       Impact factor: 4.105

2.  The relationship of cancer symptom clusters to depressive affect in the initial phase of palliative radiation.

Authors:  Richard Benoit Francoeur
Journal:  J Pain Symptom Manage       Date:  2005-02       Impact factor: 3.612

3.  Characterizing distress, the 6th vital sign, in an oncology pain clinic.

Authors:  A Waller; S L Groff; N Hagen; B D Bultz; L E Carlson
Journal:  Curr Oncol       Date:  2012-04       Impact factor: 3.677

Review 4.  The Fatigue Symptom Inventory: a systematic review of its psychometric properties.

Authors:  Kristine A Donovan; Paul B Jacobsen
Journal:  Support Care Cancer       Date:  2010-09-08       Impact factor: 3.603

Review 5.  Neurobiological studies of fatigue.

Authors:  Mary E Harrington
Journal:  Prog Neurobiol       Date:  2012-07-24       Impact factor: 11.685

Review 6.  Cancer-related fatigue and its associations with depression and anxiety: a systematic review.

Authors:  Linda F Brown; Kurt Kroenke
Journal:  Psychosomatics       Date:  2009 Sep-Oct       Impact factor: 2.386

7.  Chronic stress and regulation of cellular markers of inflammation in rheumatoid arthritis: implications for fatigue.

Authors:  Mary C Davis; Alex J Zautra; Jarred Younger; Sarosh J Motivala; Jeanne Attrep; Michael R Irwin
Journal:  Brain Behav Immun       Date:  2007-08-15       Impact factor: 7.217

Review 8.  Aiming for a better understanding and management of cancer-related fatigue.

Authors:  Elisabeth C W Neefjes; Maurice J D L van der Vorst; Susanne Blauwhoff-Buskermolen; Henk M W Verheul
Journal:  Oncologist       Date:  2013-09-13

9.  Development of a fatigue and functional impact scale in anemic cancer patients receiving chemotherapy.

Authors:  David Cella; Hema N Viswanathan; Ron D Hays; Tito R Mendoza; Kevin D Stein; David J Pasta; Aimee J Foreman; Saroj Vadhan-Raj; Joel D Kallich
Journal:  Cancer       Date:  2008-09-15       Impact factor: 6.860

10.  Prevalence and determinants of fatigue in patients with moderate to severe chronic GvHD.

Authors:  A Im; S A Mitchell; S M Steinberg; L Curtis; A Berger; K Baird; Z Kuzmina; G Joe; L E Comis; M Juckett; D Avila; J Baruffaldi; L Masuch; F Pirsl; S Z Pavletic
Journal:  Bone Marrow Transplant       Date:  2016-02-01       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.